Fallout over the FDA’s recent decision to grant Biogen’s Alzheimer’s drug accelerated approval has seen two advisory panel members resign.
  • Fox News
  • Jun 10, 2021

2 FDA committee members resign over Biogen Alzheimer's drug approval - Fox News

Fallout over the FDAs recent decision to grant Biogens Alzheimers drug accelerated approval has seen two advisory panel members resign. The agencys decision, which was met with mixed reviews and mark… [+2380 chars]

More In business